Please enable JavaScript to continue using this application.

Compare $AGIO vs $BHVN | Chartloom

Compare

$AGIO vs $BHVN

Agios Pharmaceuticals Inc · Biohaven Ltd

AGIO

Agios Pharmaceuticals Inc

BHVN

Biohaven Ltd

Compare $AGIO vs $BHVN

Comparing Agios Pharmaceuticals Inc and Biohaven Ltd

AGIOAgios Pharmaceuticals Inc

BHVNBiohaven Ltd

AGIOAgios Pharmaceuticals Inc

Market cap

$1.89B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.91x

Rev growth (TTM)

140.6%

YTD performance

17.0%

52W performance

-25.3%

FCF yield

-19.3%

BHVNBiohaven Ltd

Market cap

$1.82B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

113.82x

Rev growth (TTM)

—

YTD performance

11.4%

52W performance

-21.3%

FCF yield

-28.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AGIO

BHVN

Detailed metrics comparison

AGIO

Agios Pharmaceuticals Inc

BHVN

Biohaven Ltd

Market Cap

AGIO$1.89B

BHVN$1.82B

Enterprise Value

AGIO$1.79B

BHVN$1.84B

Price

AGIO$31.81

BHVN$12.08

P/E Ratio

AGION/A

BHVNN/A

P/S Ratio

AGIO19.24x

BHVN0.00x

EV/Sales

AGIO18.22x

BHVN0.00x

EV/EBITDA

AGIO2.84x

BHVN0.00x

P/B Ratio

AGIO1.85x

BHVN159.05x

P/FCF Ratio

AGION/A

BHVNN/A

EV/FCF

AGIO-4.91x

BHVN-3.60x

PEG Ratio

AGION/A

BHVNN/A

Forward P/E (NTM)

AGION/A

BHVNN/A

Forward P/S (NTM)

AGIO6.91x

BHVN113.82x

Revenue (TTM)

AGIO$98M

BHVN$0

Revenue Growth (YoY)

AGIO140.6%

BHVNN/A

Forward Rev Growth

AGIO92.6%

BHVN169.9%

Gross Margin (TTM)

AGIO92.0%

BHVN0.0%

Operating Margin (TTM)

AGIO0.0%

BHVN0.0%

EBITDA Margin (TTM)

AGIO-461.3%

BHVN0.0%

Net Margin (TTM)

AGIO-418.2%

BHVN0.0%

FCF Margin (TTM)

AGIO-371.4%

BHVNN/A

Net Income (TTM)

AGIO$-411M

BHVN$-587M

FCF (TTM)

AGIO$-365M

BHVN$-512M

EPS (TTM)

AGIO-$6.91

BHVN-$3.90

ROE (TTM)

AGIO-3567.0%

BHVN-63995.0%

ROA (TTM)

AGIO-3306.0%

BHVN-13827.0%

ROIC (TTM)

AGIO-3567.0%

BHVN-13277.0%

Cash

AGIO$100M

BHVN$238M

Debt

AGIO$0

BHVN$259M

Net Cash/Debt

AGIO$100M

BHVN$-21M

Current Ratio (TTM)

AGIO10.22x

BHVN4.73x

Quick Ratio (TTM)

AGIO9.14x

BHVN4.30x

Debt/Equity (TTM)

AGIO0.00x

BHVN21.23x

Debt/Assets (TTM)

AGIO0.0%

BHVN0.0%

Interest Coverage (TTM)

AGION/A

BHVNN/A

Net Debt/EBITDA (TTM)

AGIO0.00x

BHVN0.00x

Beta

AGIO0.62

BHVN3.18

52W Performance

AGIO-25.3%

BHVN-21.3%

YTD Performance

AGIO17.0%

BHVN11.4%

% from 52W High

AGIO-30.8%

BHVN-34.9%

% from 52W Low

AGIO43.0%

BHVN61.5%

Asset Turnover (TTM)

AGIO0.08x

BHVN0.00x

FCF Yield (TTM)

AGIO-19.3%

BHVN-28.1%

Earnings Yield (TTM)

AGIO-21.7%

BHVN-32.3%

Dividend Yield (TTM)

AGION/A

BHVNN/A

Rule of 40

AGIO-230.8

BHVN0.0

EV/GP/RG

AGIO0.06

BHVNN/A

Ticker research

View AGIO research View BHVN research

Metric	AGIO Agios Pharmaceuticals Inc	BHVN Biohaven Ltd
Market & Valuation
Market Cap	$1.89B	$1.82B
Enterprise Value	$1.79B	$1.84B
Price	$31.81	$12.08
P/E Ratio	N/A	N/A
P/S Ratio	19.24x	0.00x
EV/Sales	18.22x	0.00x
EV/EBITDA	2.84x	0.00x
P/B Ratio	1.85x	159.05x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.91x	-3.60x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.91x	113.82x
Revenue & Growth
Revenue (TTM)	$98M	$0
Revenue Growth (YoY)	140.6%	N/A
Forward Rev Growth	92.6%	169.9%
Profitability
Gross Margin (TTM)	92.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-461.3%	0.0%
Net Margin (TTM)	-418.2%	0.0%
FCF Margin (TTM)	-371.4%	N/A
Net Income (TTM)	$-411M	$-587M
FCF (TTM)	$-365M	$-512M
EPS (TTM)	-$6.91	-$3.90
ROE (TTM)	-3567.0%	-63995.0%
ROA (TTM)	-3306.0%	-13827.0%
ROIC (TTM)	-3567.0%	-13277.0%
Financial Health
Cash	$100M	$238M
Debt	$0	$259M
Net Cash/Debt	$100M	$-21M
Current Ratio (TTM)	10.22x	4.73x
Quick Ratio (TTM)	9.14x	4.30x
Debt/Equity (TTM)	0.00x	21.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	3.18
52W Performance	-25.3%	-21.3%
YTD Performance	17.0%	11.4%
% from 52W High	-30.8%	-34.9%
% from 52W Low	43.0%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.00x
FCF Yield (TTM)	-19.3%	-28.1%
Earnings Yield (TTM)	-21.7%	-32.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-230.8	0.0
EV/GP/RG	0.06	N/A
Ticker research	View AGIO research	View BHVN research

Valuation

P/S Ratio

BHVN

0.00x

AGIO

19.24x

EV/FCF

AGIO

-4.91x

BHVN

-3.60x

Growth & revenue

Revenue Growth TTM

AGIO

140.6%

Forward Revenue Growth

BHVN

169.9%

AGIO

92.6%

Profitability & performance

Gross Margin

AGIO

92.0%

BHVN

0.0%

ROE

AGIO

-3567.0%

BHVN

-63995.0%

FCF Yield %

AGIO

-19.3%

BHVN

-28.1%

52-Week Performance

BHVN

-21.3%

AGIO

-25.3%

Detailed metrics comparison

AGIO

Agios Pharmaceuticals Inc

BHVN

Biohaven Ltd

Market Cap

AGIO$1.89B

BHVN$1.82B

Enterprise Value

AGIO$1.79B

BHVN$1.84B

Price

AGIO$31.81

BHVN$12.08

P/E Ratio

AGION/A

BHVNN/A

P/S Ratio

AGIO19.24x

BHVN0.00x

EV/Sales

AGIO18.22x

BHVN0.00x

EV/EBITDA

AGIO2.84x

BHVN0.00x

P/B Ratio

AGIO1.85x

BHVN159.05x

P/FCF Ratio

AGION/A

BHVNN/A

EV/FCF

AGIO-4.91x

BHVN-3.60x

PEG Ratio

AGION/A

BHVNN/A

Forward P/E (NTM)

AGION/A

BHVNN/A

Forward P/S (NTM)

AGIO6.91x

BHVN113.82x

Revenue (TTM)

AGIO$98M

BHVN$0

Revenue Growth (YoY)

AGIO140.6%

BHVNN/A

Forward Rev Growth

AGIO92.6%

BHVN169.9%

Gross Margin (TTM)

AGIO92.0%

BHVN0.0%

Operating Margin (TTM)

AGIO0.0%

BHVN0.0%

EBITDA Margin (TTM)

AGIO-461.3%

BHVN0.0%

Net Margin (TTM)

AGIO-418.2%

BHVN0.0%

FCF Margin (TTM)

AGIO-371.4%

BHVNN/A

Net Income (TTM)

AGIO$-411M

BHVN$-587M

FCF (TTM)

AGIO$-365M

BHVN$-512M

EPS (TTM)

AGIO-$6.91

BHVN-$3.90

ROE (TTM)

AGIO-3567.0%

BHVN-63995.0%

ROA (TTM)

AGIO-3306.0%

BHVN-13827.0%

ROIC (TTM)

AGIO-3567.0%

BHVN-13277.0%

Cash

AGIO$100M

BHVN$238M

Debt

AGIO$0

BHVN$259M

Net Cash/Debt

AGIO$100M

BHVN$-21M

Current Ratio (TTM)

AGIO10.22x

BHVN4.73x

Quick Ratio (TTM)

AGIO9.14x

BHVN4.30x

Debt/Equity (TTM)

AGIO0.00x

BHVN21.23x

Debt/Assets (TTM)

AGIO0.0%

BHVN0.0%

Interest Coverage (TTM)

AGION/A

BHVNN/A

Net Debt/EBITDA (TTM)

AGIO0.00x

BHVN0.00x

Beta

AGIO0.62

BHVN3.18

52W Performance

AGIO-25.3%

BHVN-21.3%

YTD Performance

AGIO17.0%

BHVN11.4%

% from 52W High

AGIO-30.8%

BHVN-34.9%

% from 52W Low

AGIO43.0%

BHVN61.5%

Asset Turnover (TTM)

AGIO0.08x

BHVN0.00x

FCF Yield (TTM)

AGIO-19.3%

BHVN-28.1%

Earnings Yield (TTM)

AGIO-21.7%

BHVN-32.3%

Dividend Yield (TTM)

AGION/A

BHVNN/A

Rule of 40

AGIO-230.8

BHVN0.0

EV/GP/RG

AGIO0.06

BHVNN/A

Ticker research

View AGIO research View BHVN research

Metric	AGIO Agios Pharmaceuticals Inc	BHVN Biohaven Ltd
Market & Valuation
Market Cap	$1.89B	$1.82B
Enterprise Value	$1.79B	$1.84B
Price	$31.81	$12.08
P/E Ratio	N/A	N/A
P/S Ratio	19.24x	0.00x
EV/Sales	18.22x	0.00x
EV/EBITDA	2.84x	0.00x
P/B Ratio	1.85x	159.05x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.91x	-3.60x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.91x	113.82x
Revenue & Growth
Revenue (TTM)	$98M	$0
Revenue Growth (YoY)	140.6%	N/A
Forward Rev Growth	92.6%	169.9%
Profitability
Gross Margin (TTM)	92.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-461.3%	0.0%
Net Margin (TTM)	-418.2%	0.0%
FCF Margin (TTM)	-371.4%	N/A
Net Income (TTM)	$-411M	$-587M
FCF (TTM)	$-365M	$-512M
EPS (TTM)	-$6.91	-$3.90
ROE (TTM)	-3567.0%	-63995.0%
ROA (TTM)	-3306.0%	-13827.0%
ROIC (TTM)	-3567.0%	-13277.0%
Financial Health
Cash	$100M	$238M
Debt	$0	$259M
Net Cash/Debt	$100M	$-21M
Current Ratio (TTM)	10.22x	4.73x
Quick Ratio (TTM)	9.14x	4.30x
Debt/Equity (TTM)	0.00x	21.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	3.18
52W Performance	-25.3%	-21.3%
YTD Performance	17.0%	11.4%
% from 52W High	-30.8%	-34.9%
% from 52W Low	43.0%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.00x
FCF Yield (TTM)	-19.3%	-28.1%
Earnings Yield (TTM)	-21.7%	-32.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-230.8	0.0
EV/GP/RG	0.06	N/A
Ticker research	View AGIO research	View BHVN research